Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Beeler

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Pediatric Infectious Disease Journal|September 27, 2013
Mumps vaccines: do we need a new one?Steven Rubin, Judy Beeler
Vaccine|December 8, 2007
Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccinationBernard J Cohen, Susette Audet, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|May 12, 2016
Adverse Events After MMR or MMRV Vaccine in Infants Under Nine Months OldEmily Jane Woo, Scott K Winiecki, Deepa Arya, et al.
Plos Pathogens|April 22, 2016
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment GlycoproteinsSandra Fuentes, Elizabeth M Coyle, Judy Beeler, et al.
Vaccines|February 6, 2019
Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-GlycoproteinRoberta Lynne Crim, Sangeeta Kumari, Priyanka Jayanti, et al.
Vaccine|June 8, 2013
Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infectionSandra Fuentes, Roberta L Crim, Judy Beeler, et al.
The Journal of Infectious Diseases|June 14, 2011
Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225Sulachni Chandwani, Judy Beeler, Hong Li, et al.
Virology Journal|June 18, 2013
A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessmentJan C Varada, Belete Teferedegne, R Lynne Crim, et al.
Vaccine|December 4, 2010
Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008Emily Jane Woo, Robert P Wise, David Menschik, et al.
The Journal of Infectious Diseases|January 10, 2013
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of ageHayley A Gans, Linda L Yasukawa, Phillip Sung, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Pediatric Infectious Disease Journal|September 27, 2013
Mumps vaccines: do we need a new one?Steven Rubin, Judy Beeler
Vaccine|December 8, 2007
Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccinationBernard J Cohen, Susette Audet, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|May 12, 2016
Adverse Events After MMR or MMRV Vaccine in Infants Under Nine Months OldEmily Jane Woo, Scott K Winiecki, Deepa Arya, et al.
Plos Pathogens|April 22, 2016
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment GlycoproteinsSandra Fuentes, Elizabeth M Coyle, Judy Beeler, et al.
Vaccines|February 6, 2019
Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-GlycoproteinRoberta Lynne Crim, Sangeeta Kumari, Priyanka Jayanti, et al.
Vaccine|June 8, 2013
Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infectionSandra Fuentes, Roberta L Crim, Judy Beeler, et al.
The Journal of Infectious Diseases|June 14, 2011
Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225Sulachni Chandwani, Judy Beeler, Hong Li, et al.
Virology Journal|June 18, 2013
A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessmentJan C Varada, Belete Teferedegne, R Lynne Crim, et al.
Vaccine|December 4, 2010
Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008Emily Jane Woo, Robert P Wise, David Menschik, et al.
The Journal of Infectious Diseases|January 10, 2013
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of ageHayley A Gans, Linda L Yasukawa, Phillip Sung, et al.
Pageof 2